priors.science/reviews/ace-inhibitors-and-angiotensin-receptor-blockers

ACE Inhibitors and Angiotensin Receptor Blockers

The current evidence on 18 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty: how firmly the literature supports the claim as stated.

18claims tracked
327primary papers reviewed
23 Oct 2026latest evidence review
8 Established · 7 Likely · 2 Uncertain · 0 Doubtful · 1 Refuted  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
ACE inhibitor angioedema higher in Black patientsSafetyEstablished90%27
ACE inhibitors and ARBs reduce mortality in heart failure with reduced ejection fractionHfrefEstablished88%27
ACE inhibitors and ARBs reduce diabetic nephropathyRenalEstablished88%35
ACE inhibitors and ARBs slow proteinuric chronic kidney diseaseRenalEstablished87%28
ARBs have lower adverse drug reaction risk than ACE inhibitorsSafetyEstablished87%29
Dual blockade increases hyperkalemiaDualEstablished86%26
No renal benefit from stopping ACE inhibitors and ARBsRenalEstablished86%23
ACE inhibitor-induced cough is frequentSafetyEstablished86%28
ACE inhibitors and ARBs: similar cardiovascular protectionComparativeLikely84%28
Combined ACE inhibitor and ARB: no cardiovascular benefitDualLong-standingLikely78%26
ACE inhibitor and ARB withdrawal worsens heart failure outcomesHfrefLikely78%29
Hyperkalemia limits ACE inhibitor and ARB use in chronic kidney diseaseRenalLikely75%25
Women benefit from lower ACE inhibitor and ARB dosesHfrefLikely74%27
ACE inhibitors and ARBs reduce major adverse cardiovascular events in high cardiovascular riskCVLikely72%32
ACE inhibitors: worse cardiovascular outcomes in Black patientsCVLikely72%26
ARBs versus ACE inhibitors: lower all-cause mortalityComparativeUncertain62%31
ACE inhibitors and ARBs improve ejection fraction in dilated cardiomyopathyHfrefUncertain60%8
ACE inhibitor angioedema onset is delayedSafetyRefuted12%23
Track ACE Inhibitors and Angiotensin Receptor Blockers.
These claims are re-checked against new research as it is published. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing: what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it. Confidently false as stated.
A standing changes only when the score moves past a boundary by more than 4 points, the re-scoring noise floor; a score within 4 points of a boundary keeps its previous standing.
Where the evidence sits in time
Long-standingMost of this evidence is older than the rest of this field.